دورية أكاديمية

The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients.

التفاصيل البيبلوغرافية
العنوان: The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients.
المؤلفون: Moffatt, Clare, Lechner, Melissa G, Angell, Trevor E, Shen, John, Drakaki, Alexandra, Acosta, Gonzalo J, Liang, Tom Z, Tsai, Karen
المصدر: J Endocr Soc ; ISSN:2472-1972 ; Volume:8 ; Issue:7
بيانات النشر: PubMed Central
سنة النشر: 2024
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: apalutamide, hypothyroidism, levothyroxine, thyroid dysfunction, thyroid function tests, thyroid hormone replacement
الوصف: Apalutamide (APT) is a nonsteroidal antiandrogen medication used to treat metastatic castrate-sensitive and nonmetastatic castrate-resistant prostate cancer. Early clinical trials of APT identified thyroid dysfunction as a common adverse effect of therapy, but the clinical presentation and management of APT-induced hypothyroidism has not been studied.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.1210/jendso/bvae105Test; https://pubmed.ncbi.nlm.nih.gov/38854906Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156616Test/
DOI: 10.1210/jendso/bvae105
الإتاحة: https://doi.org/10.1210/jendso/bvae105Test
https://pubmed.ncbi.nlm.nih.gov/38854906Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156616Test/
حقوق: © The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
رقم الانضمام: edsbas.B1122070
قاعدة البيانات: BASE